Results 61 to 70 of about 11,064 (108)

Abatacept for the treatment of myositis-associated interstitial lung disease. [PDF]

Rheumatology (Oxford)
Aggarwal R, Pongtarakulpanit N, Sullivan DI, Moghadam-Kia S, Bae SS, Wilkerson J, Saygin D, Marder G, Venuturupalli S, Dellaripa PF, Danoff SK, Doyle T, Hunninghake GM, Lee JS, Fischer A, Falk J, Johnson C, Koontz D, Ascherman DP, Oddis CV.   +19 more
europepmc   +1 more source

Emerging therapeutic targets in non-infectious uveitis and scleritis. [PDF]

Front Med (Lausanne)
Tungsattayathitthan U, Goldstein DA, Janetos TM.   +2 more
europepmc   +1 more source

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease: An Emulated Target Trial. [PDF]

Arthritis Rheumatol
Shih PC, Wang SI, Wei JCC.
europepmc   +1 more source

Early Outcomes After Haploidentical Hematopoietic Cell Transplantation in Elderly Patients with Myeloid Malignancies in India: A Single Center Experience. [PDF]

Blood Cell Ther
Sinha Roy S, Potdar C, Vikrem B, Singh MK, Singh M, Chandra D, Rahman K, Gupta R, Kashyap R.   +8 more
europepmc   +1 more source

Bowenoid Actinic Keratosis in a Patient Receiving Abatacept for Rheumatoid Arthritis: A Case Report. [PDF]

Cureus
Kaga M, Amano H, Kon T, Ogura K.
europepmc   +1 more source

Successful Treatment of Anti-Jo-1 Positive Inflammatory Myopathy With Tofacitinib. [PDF]

Case Rep Rheumatol
Timsans J, Hokkanen AM, Rautavaara J, Kerola A, Huovinen S, Kauppi M.   +5 more
europepmc   +1 more source

Immune checkpoint inhibitor cardiomyotoxicity: a case series of five patients and development of a clinical management algorithm. [PDF]

Intern Med J
Xie SZ, Salem JE, Nagrial A, Menzies A, Thomas L, Ramanathan S, Berglund LJ, Sasson SC, Grey AC, Habib R, Wong M, Carlino MS, Jeffrey B, Mo J, Lin MW.   +14 more
europepmc   +1 more source

Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval. [PDF]

Diabetes
Sims EK, Russell WE, Cuthbertson D, Skyler JS, Jacobsen LM, Ismail HM, Redondo MJ, Nathan BM, Carr ALJ, Taylor PN, Dayan CM, Galderisi A, Herold KC, Sosenko JM.   +13 more
europepmc   +1 more source

Recombinant zoster vaccine in patients with inflammatory rheumatic diseases: efficacy, long-term protection and safety under immunosuppression. [PDF]

RMD Open
Krasselt M.
europepmc   +1 more source

Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study. [PDF]

Ther Adv Musculoskelet Dis
Kao CM, Shih PC, Chen DY, Chen HH.
europepmc   +1 more source